Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
Matthias Niedermeier(The University of Texas MD Anderson Cancer Center), Jan A. Burger(The University of Texas MD Anderson Cancer Center)
Cited by 142
Related Papers
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
|Blood|2005|1.2k
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
|Blood|2009|576
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
|Nature Communications|2016|345